Anika Therapeutics, Inc. (ANIK) Reports Q2 Earnings of $0.17, Revenues Increase Y/Y

Anika Therapeutics, Inc. (NASDAQ: ANIK) reported Q2 EPS of $0.17, versus $0.08 reported last year. Revenue for the quarter came in at $16.1 million, versus $13.7 million reported last year.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
• YETI Holdings, Inc. (YETI) Tops Q2 EPS by 12c
• Goldman Sachs raises Europe stock earnings forecast to 15%